Also trades as: 1801.HK (HKSE) · $vol 173M

$12.80

+0.29 (+2.33%)

Weekly Expected Move ±14.3%

$9 $11 $13 $15 $16

OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 54 · $22.3B mcap · 1.61B float · 0.0002% daily turnover · Short 55% of daily vol

Revenue

$12.7B +34.8% ▲

5Y CAGR: +27.0%

Gross Profit

$11.0B +39.0% ▲

5Y CAGR: +26.0%

Operating Income

$2.0B +360.5% ▲

Net Income

$793M +937.5% ▲

EPS (Diluted)

$0.46 +915.6% ▲

EBITDA

$2.0B +510.0% ▲

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$4.3B	$4.6B	$6.2B	$9.4B	$12.7B
YoY Growth	+11.1%	+6.7%	+36.2%	+51.8%	+34.8%
Cost of Revenue	$573M	$931M	$1.8B	$1.5B	$1.7B
Gross Profit	$3.7B	$3.6B	$4.4B	$7.9B	$11.0B
Gross Margin	86.6%	79.6%	70.9%	84.0%	86.5%
R&D Expenses	$2.5B	$2.9B	$2.2B	$2.7B	$2.6B
SG&A Expenses	$3.6B	$3.4B	$3.9B	$5.1B	$6.5B
Operating Expenses	$5.7B	$6.2B	$6.1B	$7.7B	$9.0B
Operating Income	-$2.7B	-$3.1B	-$1.7B	-$756M	$2.0B
Operating Margin	-63.3%	-68.5%	-27.1%	-8.0%	15.5%
Interest Expense	$62M	$102M	$99M	$68M	$78M
Income Before Tax	-$2.6B	-$2.2B	-$1.1B	-$79M	$817M
Tax Expense	$87M	$9M	-$116M	$16M	$25M
Net Income	-$2.7B	-$2.2B	-$1.0B	-$95M	$793M
Net Margin	-63.9%	-47.8%	-16.6%	-1.0%	6.2%
EPS (Diluted)	$-1.88	$-1.46	$-0.66	$-0.06	$0.46
EBITDA	-$2.4B	-$1.7B	-$661M	-$480M	$2.0B
Shares Outstanding	1.46B	1.49B	1.56B	1.63B	1.74B

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$2.3B	$2.7B	$3.5B	$4.0B	$5.5B	$6.0B	$7.0B	$8.5B
Cost of Revenue	$673M	$782M	$1.0B	$1.1B	$1.3B	$1.4B	$907M	$1.3B
Gross Profit	$1.6B	$1.9B	$2.5B	$2.9B	$4.2B	$4.6B	$6.1B	$7.2B
Gross Margin	70.9%	71.1%	70.7%	72.3%	75.9%	77.3%	87.0%	85.0%
R&D Expenses	$1.7B	$923M	$1.3B	$1.4B	$1.3B	$1.0B	$1.6B	$1.7B
SG&A Expenses	$1.6B	$1.7B	$2.1B	$2.2B	$2.9B	$2.8B	$3.8B	$3.7B
Operating Expenses	$2.9B	$2.1B	$3.4B	$3.6B	$4.2B	$3.8B	$5.3B	$5.3B
Operating Income	-$1.7B	-$719M	-$960M	-$741M	-$15M	$774M	$716M	$1.9B
Operating Margin	-72.3%	-26.6%	-27.4%	-18.7%	-0.3%	13.0%	10.3%	22.1%
Interest Expense	$0	$0	$0	$0	$0	$0	$18M	$40M
Income Before Tax	-$1.2B	-$256M	-$888M	-$393M	$314M	$897M	-$57M	$1.6B
Tax Expense	$57M	-$117M	$462K	$35K	$16M	$63M	-$37M	$354M
Net Income	-$1.2B	-$139M	-$889M	-$393M	$298M	$834M	-$20M	$1.2B
Net Margin	-53.0%	-5.2%	-25.4%	-9.9%	5.4%	14.0%	-0.3%	14.5%
EPS (Diluted)	$-0.82	$-0.09	$-0.56	$-0.24	$0.18	$0.49	$-0.02	$0.68
EBITDA	-$1.5B	-$547M	-$742M	-$249M	-$231M	$1.0B	$1.0B	$2.2B
Shares Outstanding	1.52B	1.54B	1.58B	1.62B	1.63B	1.69B	829M	1.80B

IVBXF OTC